Very few new molecular entities in active clinical development are readily bioavailable, and, when dosed at escalated levels, even these may not be sufficiently absorbed. Learn how spray-dried amorphous dispersion might help.
Arguably the biggest challenge in pediatric oral solid formulation development is to develop flexible dosage forms with measurable and easy-to-administer dosages, preferably formulated with taste-masking properties for better acceptance of the drug formulation in children. This Q&A session with formulation and bioavailability experts addresses formulation challenges for pediatric populations and how they are overcoming them.
Watch this webinar to learn more about the importance of recent developments in lipid-based drug delivery systems, novel lipid excipients, models, screening tools for early-phase development of lipid-based drug delivery systems, and using mechanistic studies and modeling to predict the impact of lipids on oral absorption.